后中国血管成形术和支架置入术治疗症状性颅内严重狭窄时代的发展方向是什么?

IF 2.3 4区 医学 Q3 CLINICAL NEUROLOGY
Fang Xue, Ho Jun Yun, Liwei Peng, Chuanjie Wu
{"title":"后中国血管成形术和支架置入术治疗症状性颅内严重狭窄时代的发展方向是什么?","authors":"Fang Xue,&nbsp;Ho Jun Yun,&nbsp;Liwei Peng,&nbsp;Chuanjie Wu","doi":"10.4103/bc.bc_68_22","DOIUrl":null,"url":null,"abstract":"<p><p>Symptomatic intracranial atherosclerotic disease (ICAD) is a globally challengeable disease. In the past 20 years, people have made a huge effort to deal with the problem including using endovascular technology and aggressive medical therapy. However, the efficacy of these methods seemed to be limited. The recent China angioplasty and stenting for symptomatic intracranial severe stenosis (CASSISS) did not support the addition of percutaneous transluminal angioplasty and stenting to medical therapy for the treatment of patients with symptomatic severe ICAD. So where are we heading in the post-CASSISS era?</p>","PeriodicalId":9288,"journal":{"name":"Brain Circulation","volume":"9 1","pages":"3-5"},"PeriodicalIF":2.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fe/2d/BC-9-3.PMC10158658.pdf","citationCount":"0","resultStr":"{\"title\":\"Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?\",\"authors\":\"Fang Xue,&nbsp;Ho Jun Yun,&nbsp;Liwei Peng,&nbsp;Chuanjie Wu\",\"doi\":\"10.4103/bc.bc_68_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Symptomatic intracranial atherosclerotic disease (ICAD) is a globally challengeable disease. In the past 20 years, people have made a huge effort to deal with the problem including using endovascular technology and aggressive medical therapy. However, the efficacy of these methods seemed to be limited. The recent China angioplasty and stenting for symptomatic intracranial severe stenosis (CASSISS) did not support the addition of percutaneous transluminal angioplasty and stenting to medical therapy for the treatment of patients with symptomatic severe ICAD. So where are we heading in the post-CASSISS era?</p>\",\"PeriodicalId\":9288,\"journal\":{\"name\":\"Brain Circulation\",\"volume\":\"9 1\",\"pages\":\"3-5\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fe/2d/BC-9-3.PMC10158658.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain Circulation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4103/bc.bc_68_22\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Circulation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/bc.bc_68_22","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

症状性颅内动脉粥样硬化疾病(ICAD)是一种全球性的挑战疾病。在过去的20年里,人们已经做出了巨大的努力来解决这个问题,包括使用血管内技术和积极的医学治疗。然而,这些方法的功效似乎是有限的。最近的中国血管成形术和支架置入术治疗症状性颅内严重狭窄(CASSISS)不支持在药物治疗中增加经皮腔内血管成形术和支架置入术治疗症状性重度ICAD患者。那么,在后cassiss时代,我们将走向何方?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?

Symptomatic intracranial atherosclerotic disease (ICAD) is a globally challengeable disease. In the past 20 years, people have made a huge effort to deal with the problem including using endovascular technology and aggressive medical therapy. However, the efficacy of these methods seemed to be limited. The recent China angioplasty and stenting for symptomatic intracranial severe stenosis (CASSISS) did not support the addition of percutaneous transluminal angioplasty and stenting to medical therapy for the treatment of patients with symptomatic severe ICAD. So where are we heading in the post-CASSISS era?

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Brain Circulation
Brain Circulation Multiple-
自引率
5.30%
发文量
31
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信